Anika Therapeutics (ANIK)
(Delayed Data from NSDQ)
$25.58 USD
-0.32 (-1.24%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $25.59 +0.01 (0.04%) 7:58 PM ET
2-Buy of 5 2
C Value A Growth F Momentum B VGM
Detailed Estimates
EPS Estimates
Earnings Date | *AMC5/8/24 |
---|---|
Current Quarter | -0.19 |
EPS Last Quarter | -4.30 |
Last EPS Surprise | -1,553.85% |
ABR | 2.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 0.01 |
Next Year | 0.16 |
EPS (TTM) | -5.65 |
P/E (F1) | 5,180.00 |
% EPS Growth Estimates | ANIK | IND | S&P |
---|---|---|---|
Current Qtr (03/2024) | 73.24 | 5,941.58 | 14.20 |
Next Qtr (06/2024) | 100.00 | 161.80 | 11.23 |
Current Year (12/2024) | 100.18 | 12.90 | 17.08 |
Next Year (12/2025) | 1,500.00 | 8.30 | 8.00 |
Past 5 Years | -168.60 | 1.00 | 8.10 |
Next 5 Years | 10.00 | 19.90 | NA |
PE | 5,180.00 | -1.10 | 20.29 |
PEG Ratio | 518.00 | -0.06 | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 39.23M | 41.24M | 169.82M | 179.18M |
# of Estimates | 1 | 1 | 1 | 1 |
High Estimate | 39.23M | 41.24M | 169.82M | 179.18M |
Low Estimate | 39.23M | 41.24M | 169.82M | 179.18M |
Year ago Sales | 37.92M | 44.30M | 166.66M | 169.82M |
Year over Year Growth Est. | 3.45% | -6.91% | 1.89% | 5.51% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.19 | 0.00 | 0.01 | 0.16 |
# of Estimates | 1 | 1 | 2 | 2 |
Most Recent Consensus | -0.19 | 0.00 | -0.20 | -0.01 |
High Estimate | -0.19 | 0.00 | 0.21 | 0.33 |
Low Estimate | -0.19 | 0.00 | -0.20 | -0.01 |
Year ago EPS | -0.71 | -0.19 | -5.64 | 0.01 |
Year over Year Growth Est. | 73.24% | 100.00% | 100.18% | 1,550.00% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 1 | 0 |
Up Last 60 Days | 1 | 1 | 2 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.19 | 0.00 | 0.01 | 0.16 |
7 Days Ago | -0.19 | 0.00 | 0.01 | 0.16 |
30 Days Ago | -0.19 | 0.00 | -0.20 | -0.01 |
60 Days Ago | -0.22 | -0.10 | -0.40 | -0.33 |
90 Days Ago | -0.22 | -0.10 | -0.40 | -0.33 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.19 | 0.00 | 0.21 | 0.33 |
Zacks Consensus Estimate | -0.19 | 0.00 | 0.01 | 0.16 |
Earnings ESP | 0.00% | 0.00% | 4,100.00% | 106.25% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -4.30 | -0.45 | -0.19 | -0.71 | NA |
Estimate | -0.26 | -0.33 | -0.34 | -0.36 | NA |
Difference | -4.04 | -0.12 | 0.15 | -0.35 | -1.09 |
Surprise | -1,553.85% | -36.36% | 44.12% | -97.22% | -410.83% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more